Sub Banner Image

BioNTech Says Experimental Cancer Drug Succeeded in Trial

Markets

Naomi Kresge, Amber Tong

·

September 5, 2025

·

Bloomberg

BioNTech SE said an experimental drug succeeded in a breast cancer study, the first dividend of the German Covid-19 vaccine maker’s collaboration with Chinese biotech Duality Biotherapeutics Inc.

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.